Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins.
An enzyme-linked immunosorbent assay (ELISA) based on recombinant nucleocapsid protein (rN delta) (aa 1-117) of Hantaan, Seoul, Dobrava, Sin Nombre and Puumala hantaviruses was used to determine the prevalence of antibodies among randomized and stratified individuals from northern Sweden. In total, 137/1533 individuals (8.9%) had specific serum IgG antibodies to Puumala virus, the only hantavirus known to occur in the region. The prevalence of antibodies to Puumala virus (8.9%) was determined to be higher than previously reported (5.4%) in the same serum material, by use of immunofluorescence assay. As expected, sera reactive to Puumala virus rN delta did frequently cross-react with Sin Nombre virus protein. Unexpectedly, 21/1533 (1.4%) individuals recognized the Sin Nombre virus rN delta exclusively. Another 8 subjects showed reactivity in the ELISA to Hantaan, Seoul, or Dobrava virus-derived rN delta but not Puumala virus or Sin Nombre virus rN delta. The present demonstration in some individuals of antibodies specifically recognizing the Sin Nombre, Dobrava, Hantaan and Seoul virus protein justifies an awareness of the possibility that hantaviruses antigenically different from Puumala virus might occur in the region.
Ahlm
C
C
Department of Infectious Diseases, University of Umeå, Sweden.
Juto
P
P
Stegmayr
B
B
Settergren
B
B
Wadell
G
G
Tärnvik
A
A
Elgh
F
F
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis* / Q000276:immunology; D015153:Blotting, Western; D003429:Cross Reactions / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006476:Orthohantavirus / Q000235:genetics / Q000276:immunology; D018778:Hantavirus Infections / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D019251:Nucleocapsid / Q000235:genetics / Q000276:immunology; D015995:Prevalence; D011994:Recombinant Proteins / Q000276:immunology; D016036:Seroepidemiologic Studies; D013548:Sweden / Q000453:epidemiology
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D011994:Recombinant Proteins